Vitalibis Net debt/EBITDA
Quel est le Net debt/EBITDA de Vitalibis?
Le Net debt/EBITDA de Vitalibis, Inc. est -1.71
Quelle est la définition de Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA des entreprises dans Health Care secteur sur OTC par rapport à Vitalibis
Que fait Vitalibis?
Vitalibis, Inc. operates as a technology-based formulator of phytocannabinoid rich hemp products with cannabidiol, along with personal care and nutritional products. The company markets and sells consumer products under the Vitalibis brand. It also sells water soluble phytocannabinoid rich hemp powder. The company was formerly known as Sheng Ying Entertainment Corp. and changed its name to Vitalibis, Inc. in February 2018. Vitalibis, Inc. was founded in 2014 and is based in Las Vegas, Nevada. On June 15, 2020, Vitalibis, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Nevada.
Entreprises avec net debt/ebitda similaire à Vitalibis
- Sisram Medical Ltd a Net debt/EBITDA de -1.72
- Monarch Mining a Net debt/EBITDA de -1.72
- Jaguar Mining a Net debt/EBITDA de -1.72
- Medpace Inc a Net debt/EBITDA de -1.72
- Varian Medical Systems a Net debt/EBITDA de -1.72
- Miller Industries a Net debt/EBITDA de -1.71
- Vitalibis a Net debt/EBITDA de -1.71
- CareCloud Inc a Net debt/EBITDA de -1.71
- Sunlight Technology a Net debt/EBITDA de -1.71
- Anglo Asian Mining Plc a Net debt/EBITDA de -1.70
- Jericho Ventures a Net debt/EBITDA de -1.70
- Jericho Oil a Net debt/EBITDA de -1.70
- Home Control International a Net debt/EBITDA de -1.70